Shareholders v Threshold Pharmaceuticals, Inc.
INVESTOR ALERT: Threshold Investors Have Only Until 9/4/07 To Request Lead Plaintiff Positions
Kahn Swick Foti, LLC ("KSF") announces that shareholders of Threshold Pharmaceuticals, Inc. ("Threshold" or the "Company") (Nasdaq:THLD - News) who purchased shares of the Company between February 4, 2005 and July 14, 2006 (the "Class Period"), including purchasers of shares pursuant to Threshold's February 4, 2005 Initial Public Offering ("IPO") and its October 12, 2005 follow-on offering, have until September 4, 2007 to move for appointment as Lead Plaintiff in a securities class action lawsuit currently pending in the United States District Court for the Southern District of New York. No class has yet been certified in this action.
If you purchased shares of Threshold in connection with the IPO or if you purchased shares thereafter in the open market, you are urged to contact Lewis Kahn, Managing Partner, KSF, toll free 1-866-467-1400, ext. 100, via cell phone at 504-301-7900, or by email at the link above to learn about your legal rights and how this action may benefit you.
